Becton Dickinson to Pay $175 Million for Misleading Investors …

Dec 16, 2024 · The Securities and Exchange Commission today announced settled charges against Becton, Dickinson and Company, a New Jersey-based medical device manufacturer …

$175
OFF

Becton Dickinson To Pay $175 Million For Misleading Investors …

3 weeks from now

Dec 16, 2024 · The Securities and Exchange Commission today announced settled charges against Becton, Dickinson and Company, a New Jersey-based medical device manufacturer …

sec.gov

$175
OFF

BD To Pay $175M To Settle Charges Of Misleading Investors On …

3 weeks from now

Dec 17, 2024 · Dive Brief: BD will pay a $175 million civil penalty to settle charges from the Securities and Exchange Commission that the company misled investors about problems with …

medtechdive.com

$175
OFF

Becton, Dickinson To Pay $175M To Settle Claims Over Misleading …

3 weeks from now

The SEC on Monday said that Becton, Dickinson (NYSE:BDX) agreed to pay a $175M civil penalty to settle charges that it misled investors regarding the risks associated with continued …

msn.com

$175
OFF

BD Agrees To Pay $175 Mln To Settle With SEC Over Alaris System ...

3 weeks from now

Dec 17, 2024 · The Securities and Exchange Commission announced settled charges against BD for repeatedly misleading investors about risks associated with its continued sales of its Alaris …

businessinsider.com

$175
OFF

Becton Dickinson To Pay $175 Million For Misleading Investors

3 weeks from now

Dec 16, 2024 · The Securities and Exchange Commission today announced settled charges against Becton, Dickinson and Company, a New Jersey- based medical device manufacturer …

nasdaq.com

$175
OFF

BD Pays $175M To Settle SEC Claims It Failed To Report Infusion …

3 weeks from now

Dec 17, 2024 · The Securities and Exchange Commission (SEC) today announced settled charges against Becton, Dickinson and Company (BD), a New Jersey-based medical device …

medicaldesigndevelopment.com

$175
OFF

Becton Dickinson Pays $175M For Misleading Investors About …

3 weeks from now

Dec 18, 2024 · Becton Dickinson (BD) medical device company will pay $175 million for “repeatedly” misleading investors about its Alaris infusion pump, a product the company knew …

complianceweek.com

$175
OFF

Becton Dickinson To Pay $175 Million To Settle SEC Probe

3 weeks from now

Dec 16, 2024 · Becton, Dickinson & Co. has agreed to a $175 million fine over Securities and Exchange Commission claims it repeatedly misled investors about one of its most …

bloomberg.com

$175
OFF

Financial Crime Weekly: Becton, Dickinson And Co. Pays $175

3 weeks from now

Dec 21, 2024 · The Securities and Exchange Commission on Monday announced it had settled charges against Becton, Dickinson and Company BDX, known as BD, for repeatedly …

benzinga.com

$175
OFF

BD Agrees To Pay $175 Mln To Settle With SEC Over Alaris System ...

3 weeks from now

Dec 17, 2024 · Becton, Dickinson and Co. or BD, a New Jersey-based medical device manufacturer, has agreed to pay $175 million to the U.S. Securities and Exchange …

rttnews.com

$175
OFF

Becton Dickinson To Pay $175 Million For Misleading Investors …

3 weeks from now

Dec 16, 2024 · Washington, D.C.--(Newsfile Corp. - December 16, 2024) - The Securities and Exchange Commission today announced settled charges against Becton, Dickinson and …

streetinsider.com

$175
OFF

Becton Dickinson To Pay $175 Million For Misleading Investors …

3 weeks from now

Tai Mo Shan to Pay $123 Million for Negligently Misleading Investors About Stability of Terra USD <hr> SEC Adopts Rule Amendments to the Broker-Dealer Customer Protection Rule <hr> …

seclaw.com

$175
OFF

BD Reaches $175M SEC Settlement Over Alaris System Disclosures ...

3 weeks from now

Dec 16, 2024 · BD (BDX) has reached a settlement with the SEC regarding an investigation into previous disclosures about the BD Alaris™ System, acquired from CareFusion in 2015.The …

stocktitan.net

$175
OFF

SEC: Becton Dickinson (BDX) To Pay $175M For Misleading Investors

3 weeks from now

Dec 16, 2024 · SEC: Becton Dickinson (BDX) to Pay $175M for misleading investors December 16, 2024 4:32 PM ... 2024 4:34 PM EST) The Securities and Exchange Commission today …

streetinsider.com

$175
OFF

BD Pays $175M To Resolve Alaris Infusion Pump Financial Fraud …

3 weeks from now

The settlement with the SEC closes out safety issues around the company’s Alaris infusion pumps. BD reportedly failed to alert investors or the FDA of known problems with the infusion …

citeline.com

$175
OFF

BD To Pay $175M To Settle Charges Of Misleading Investors On …

3 weeks from now

Dec 17, 2024 · BD to pay $175M to settle charges of misleading investors on Alaris pump Leave a Comment / By / 17/12/2024 17/12/2024 BD will pay a civil penalty to resolve charges it …

convitgroup.com

$175
OFF

Becton Dickinson's $175 Million Lesson: Misleading Investors

3 weeks from now

Dec 17, 2024 · Detailed Analysis of the Latest SEC Press Release: Becton Dickinson to Pay $175 Million for Misleading Investors About Alaris Infusion Pump Introduction The recent press …

linkedin.com

$175
OFF

BD Reaches Agreement To Resolve Most Existing Hernia Litigation

3 weeks from now

Oct 2, 2024 · BD Agrees To Pay $175 Mln To Settle With SEC Over Alaris System Investigation RTTNews 12d Becton, Dickinson to pay $175M to settle claims over misleading investors

businessinsider.com

$175
OFF

BD To Pay $175M To Settle Claims Of Misleading Investors

3 weeks from now

Dec 17, 2024 · According to the SEC, BD repeatedly misled investors about risks related to its continued Alaris infusion pump sales. Continue to Medical Product Outsourcing. Magazine. …

mpo-mag.com

FAQs about Becton Dickinson to Pay $175 Million for Misleading Investors … Coupon?

Why did the SEC settle charges against BD?

The Securities and Exchange Commission announced settled charges against BD for repeatedly misleading investors about risks associated with its continued sales of its Alaris infusion pump and for overstating its income by failing to record the costs of fixing multiple software flaws with the pump. ...

Why did BD pay $175 million to the SEC?

(RTTNews) - Becton, Dickinson and Co. (BDX) or BD, a New Jersey-based medical device manufacturer, has agreed to pay $175 million to the U.S. Securities and Exchange Commission to resolve an investigation concerning past public disclosures and SEC reporting related to the BD Alaris System. ...

Will bd pay out a settlement?

“BD is confident in both the design of its products and fulfilling its obligation to provide information about both the risks and the benefits of its products,” the company said. The settlement will be paid out over a multi-year period. ...

Did BD pay a $175 million civil penalty?

BD agreed to pay a $175 million civil penalty. According to the SEC’s order, BD determined in 2016 that software changes made to the Alaris pump required regulatory clearance from the Food and Drug Administration (FDA). ...

Why did BD make misleading statements about regulatory risks?

Rather than inform investors that these issues heightened the risk that the FDA would limit BD's ability to continue selling Alaris—a product whose sales contributed about 10 percent of BD's profits—BD made misleading statements in its periodic reports about its regulatory risks. ...

Why did BD keep investors in the dark about Alaris?

“BD repeatedly painted a misleading picture of its Alaris infusion pump for investors and then doubled down by keeping them in the dark when the device’s issues came to a head with the FDA in late 2019,” said Sanjay Wadhwa, Acting Director of the SEC’s Division of Enforcement. ...